KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Other Working Capital Changes (2017 - 2026)

Alnylam Pharmaceuticals (ALNY) has disclosed Other Working Capital Changes for 18 consecutive years, with $3.0 million as the latest value for Q1 2026.

  • For Q1 2026, Other Working Capital Changes fell 90.86% year-over-year to $3.0 million; the TTM value through Mar 2026 reached $87.9 million, up 150.51%, while the annual FY2025 figure was $117.7 million, 150.0% up from the prior year.
  • Other Working Capital Changes hit $3.0 million in Q1 2026 for Alnylam Pharmaceuticals, down from $71.0 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $84.6 million in Q3 2025 and bottomed at -$236.4 million in Q3 2024.
  • Average Other Working Capital Changes over 5 years is -$10.1 million, with a median of -$8.8 million recorded in 2023.
  • On a YoY basis, Other Working Capital Changes climbed as much as 6979.93% in 2024 and fell as far as 681.16% in 2024.
  • Alnylam Pharmaceuticals' Other Working Capital Changes stood at -$34.2 million in 2022, then skyrocketed by 31.57% to -$23.4 million in 2023, then skyrocketed by 45.25% to -$12.8 million in 2024, then surged by 654.18% to $71.0 million in 2025, then tumbled by 95.78% to $3.0 million in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at $3.0 million, $71.0 million, and $84.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.